LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3973 | 4203 | 0.9462 | 0.9399 |
MCF7 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3764 | 4012 | 0.9401 | 0.9300 |
MCF7 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3526 | 4203 | 0.8395 | 0.8144 |
MCF7 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3368 | 4012 | 0.8399 | 0.8082 |
MCF7 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2627 | 4203 | 0.6260 | 0.5408 |
MCF7 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2825 | 4012 | 0.7044 | 0.6328 |
MCF7 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1448 | 4203 | 0.3453 | 0.1057 |
MCF7 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 1785 | 4012 | 0.4452 | 0.2523 |
MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1029 | 4203 | 0.2447 | -0.0877 |
MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 986 | 4012 | 0.2453 | -0.1134 |
MCF7 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1209 | 664 | 4203 | 0.1578 | -0.2854 |
MCF7 | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1209 | 793 | 4012 | 0.1971 | -0.2200 |
MCF7 | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4167 | 4203 | 0.9925 | 0.9916 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3892 | 4203 | 0.9250 | 0.9137 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3943 | 4203 | 0.9385 | 0.9308 |
MCF7 | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3997 | 4203 | 0.9494 | 0.9410 |
MCF7 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 4047 | 4203 | 0.9636 | 0.9591 |
MCF7 | Brivanib | 10 | uM | LJP5 | 72 | hr | 1209 | 3821 | 4203 | 0.9091 | 0.8963 |
MCF7 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3736 | 4012 | 0.9315 | 0.9200 |
MCF7 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3607 | 4012 | 0.9002 | 0.8826 |
MCF7 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3606 | 4012 | 0.8988 | 0.8803 |
MCF7 | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 3242 | 4012 | 0.8082 | 0.7683 |
MCF7 | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3034 | 4012 | 0.7552 | 0.6989 |
MCF7 | CHIR-99021 | 10 | uM | LJP6 | 72 | hr | 1209 | 1880 | 4012 | 0.4689 | 0.2901 |
MCF7 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4004 | 4012 | 0.9976 | 0.9968 |